Scientific Programme

Markku Ollikainen
Chair of the Finnish Climate Change Panel

Markku Ollikainen will open the congress by discussing the direct and indirect effects global warming will have on our lives. Ollikainen is a Professor of Environmental and Resources Economics at the University of Helsinki. Since 2019, he has been the Chair of the Finnish Climate Change panel, an independent advisory council of top-level Finnish scholars that promotes the dialogue between science and policy-making.

Harri Gustavsberg
PhD, MBA in Safety Management

In the closing lecture, award-winning author, speaker and coach Harri Gustafsberg will be discussing how to prepare for challenging situations in the future. Gustafsberg worked in the Finnish Police Rapid Response Unit for over 20 years so he has plenty of experience in preparing for crisis situations.

Johan Bjerner
MD, PhD, Clinical Consultant in Medical Biochemistry
Fürst medisinsk laboratorium
Norway

MD, PhD and Clinical Consultant in Medical Biochemistry with a broad experience of everyday practice in Laboratory Medicine. Current research interests: Quality control, digital communication, mathematical models in medicine, databases, machine learning and cancer epidemiology. Bjerner has performed technical assessments since 2006 in Norway and Sweden, mainly for medical laboratories.

Patrick Bossuyt
PhD, professor of clinical epidemiology
Amsterdam University Medical Centers
The Netherlands

Patrick M. Bossuyt is a professor of Clinical Epidemiology at the Amsterdam University Medical Centers, where he leads the Biomarker and Test Evaluation research program. The BiTE program aims to appraise and develop methods for evaluating medical tests and biomarkers, with an emphasis on clinical performance, and to apply these methods in relevant clinical studies. Dr Bossuyt spearheaded the STARD initiative for the improved reporting of diagnostic test accuracy studies.

Abdurrahman Coşkun
Professor, PhD
Acibadem Mehmet Ali Aydinlar University
Turkey

Dr. Coşkun is Full Professor of Medical Biochemistry at Acibadem Mehmet Ali Aydinlar University School of Medicine (Istanbul, Turkey). His research interests are Biological variation, Measurement uncertainty, Personalized laboratory medicine, Reference intervals, Quality control and standardization, Biomarkers, and Biomedical metrology He is the Chair of the EFLM Practical Approach to Measurement Uncertainty Task and Finish Group and expert/consultant of the EFLM Biological Variation Working Group and member of Biological Variation Database Task Group. He is also member of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force group on Global Reference Interval Database (G-RID).

Verena Haselmann
Deputy Director
Institute of Clinical Chemistry, University Medicine Mannheim

Ffion Jackson
Global Sustainable Chemicals Lead
Siemens Healthineers – Diagnostics

Ffion Jackson is Global Lead for Sustainable Chemicals at Siemens Healthineers. Based in the UK and initially joining SHS in 2009 she has extensive operational experience of implementing global environmental regulation in the medical device sector. Initially as Environment, Health & Safety manager in IVD diagnostic manufacturing, then leading global REACH Authorisation and Restriction projects before becoming Head of Environmental Protection for the Laboratory Diagnostics division. She now leads global strategic projects, plans and directs research and guidance, and leads coordination programmes for compliance with chemical regulatory requirements in all regions. Initially an Environmental Specialist with the global mining company Rio Tinto coordinating environmental protection permits in the metal smelting industry, she has a Bachelor of Science degree in Oceanography and Geography and a Level 6 diploma in Occupational Health & Safety.

Anders Kallner
Associate Professor
Karolinska University Hospital
Sweden

Nelli Karhu
Senior Inspector at Finnish Medicines Agency Fimea

Senior Inspector in the supervision of in vitro diagnostic (IVD) medical devices at Fimea. Its remit includes providing guidance and advice to those involved in the sector, market surveillance, incident handling and cooperation at EU level to promote uniform, well-functioning European equipment legislation. Prior to joining the authority, Nelli has worked e.g. in IVD and bioscience companies in research and development and in the university world investigating the packaging mechanisms and evolution of viral genomes.

Piet Meijer
PhD, Director
ECAT Foundation
The Netherlands

Piet Meijer is the director of the ECAT Foundation, a non-profit global provider of external quality control in the field of thrombosis and haemostasis. He is a member of several national and international societies in the field of thrombosis and haemostasis and external quality assessment. He is an expert member of the EQALM/EFLM Post-Analytical Working Group. He chairs the ICSH (International Committee of Standardization in Haematology) guideline group on Factor VIII and IX inhibitors. He is the International advisor for the ProMeQuaLab project (quality improvement in medical laboratories in Portuguese-speaking developing countries). He is a member of the IFCC Working Group on PT/INR Standardization.

Tomris Ozben
President of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
Turkey

EuSpLM, PhD, D.Sc., and Specialist in Clinical Biochemistry, Prof Ozben is the current President of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). She has been the Chair or Member of many Federations, Scientific Organizations, Societies, Committees and Councils. She is the Past-IFCC Treasurer, Past-Chair of the IFCC Congress and Conference Committee, Past-President of the Balkan Clinical Laboratory Federation (BCLF), and one of the Board of Directors of the IFCC Foundation for Emerging Nations (FEN). Additionally, she has recently been chosen as the president-elect of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).

Sverre Sandberg
Professor, Director
Noklus
Norway

Professor Sverre Sandberg is the director of the Norwegian Quality Improvement of Laboratory examinations (NOKLUS) and the Norwegian Porphyria Center (NAPOS). He has been chair of the Committee on Evidence-Based Laboratory Medicine in IFCC, president of the European Organization for External Quality Assurance Providers in Laboratory Medicine (EQALM), president of the European Federation of Clinical chemistry and Laboratory Medicine, EFLM and board member of IFCC. He is currently the president of the European Porphyria Network Association (EPNET) and chair of the council of International cooperation for harmonisation of clinical laboratory results (ICHCLR). He is chair of the EFLM TG of the biological variation database.

Rita Selby
MBBS, FRCP(C), MSc. Associate Professor, Department of Laboratory Medicine and Medicine
University of Toronto
Canada

Dr Rita Selby is a haematologist specialising in thrombosis and hemostasis, and the medical director for two regional reference coagulation laboratories at both the University Health Network and Sunnybrook Health Sciences Centre, two quaternary care academic teaching hospitals fully affiliated with the University of Toronto. She is an Associate Professor in the departments of Laboratory Medicine & Medicine at the University of Toronto. Her research interests include coagulation laboratory quality assurance, appropriate utilization of laboratory testing and pragmatic clinical trials in anticoagulation and thromboembolism.

Marta Carnielli
Head of Certification IVD
TUV SUD
Germany

Marta Carnielli works for TUV SUD as Head of Certification IVD; in this role, she is responsible for the certification process for IVD medical devices as well as ensuring accreditations, designation and authorization relevant to IVDs are maintained by TUV Sud. She is representing TÜV SÜD in regulatory committees and conferences and support management and technical experts with the interpretation of regulatory requirements. She is the Co-Chair of the IVD Notified Bodies Working Group Prior to joining TÜV SÜD, Marta worked for Ortho Clinical Diagnostics where she held various roles of increasing responsibility within Customer Technical Support and the Quality, Regulatory and Compliance department. In her most recent role, she was Senior Manager, QRC EMEA; in this role, she was responsible for quality, regulatory and compliance activities related to the commercial business in Europe, Russia, CIS, Africa and the Middle East.

Clara Morgane
Reagent Labeling & Test Setting Team Leader
Stago
France

Clara Morgane joined Stago in 2010 and has been a part of the Labeling Department since 2011. She has experience in IVD labelling regulation and has since contributed to the implementation of the digitalization of IFUs at Stago.

Filip Heitbrink
Co-founder and CEO
Scilife
Belgium

Filip Heitbrink, cofounder and CEO at Scilife, the first Smart Quality Platform™ (for Life Sciences) Motivated by challenges, positive, hungry to learn, fearless, life-embracing, and logical, Filip embodies the essence of the company. He also knows a thing or two about building software solutions that break the status quo. An entrepreneur from a young age, Filip’s ambition to continually be on the cutting edge of tech is unbreakable, and his enthusiasm is infectious. Highly experienced in orchestrating state-of-the-art solutions for regulated industries, he is passionate about helping (thousands of) life science professionals around the world to make quality a smart culture, improve processes, and reach peak performance to drive value-creating outcomes. His ultimate dream? Putting a dent in the universe by using tech to solve problems.

Riikka Juuma
Development manager
Hansel
Finland

Riikka Juuma works as a development manager at Hansel (Central Procurement Company) consulting public organizations in procurement leadership and sustainability. She is an enthusiastic expert on sustainable public procurement. She has previously worked for several years at HUS (Helsinki University Hospital) developing sustainable procurement practices in the healthcare sector.

Toni Kajantola
Test Manager
HUS
Finland

Toni Kajantola has been focusing on digital services and device testing for the last 20 years. In his current role as a HUS IT Test manager, he is responsible for testing processes, partnerships and frame agreements.

Jussi Kurittu
Managing Director
Triolab Oy I Triolab Baltic OÜ
Finland

Managing Director of Triolab Oy covering Finland and Triolab Baltic OÜ covering Estonia, Latvia and Lithuania. Triolab Group is one of the leading distributors of medical devices in the Nordic and Baltic countries. Jussi has over 25 years of experience in the medical devices industry both in manufacturing and distribution.

Ilpo Kuronen
PhD, CTO
Reagena
Finland

Dr Ilpo Kuronen has a long history of management of the MD and IVD companies. He has worked in various executive roles in R&D, quality assurance and business development. Currently, he works as a CTO in Reagena Ltd and is responsible for technology and business development.

Sandra Liede
Senior Legal Specialist
Healthtech Finland

Sandra Liede is a Finnish lawyer with wide-ranging expertise in the healthtech field. She has special expertise in public policy and legislative issues of health technology and medical devices, genomics, biobanking, health data processing and data governance. Sandra is experienced in partnering with national & EU institutions and stakeholder groups.

Anu Mahlamäki
Medical Advisor
Kustannus Oy Duodecim
Finland

Minna Makki
Researcher
Finland

Minna Makki has in cooperation with Healthtech Finland member companies conducted research on the status of sustainability of medical device manufacturers based in Finland. She has worked as a Customer Experience and Quality Lead at a small medical device manufacturer. Her hands-on experience includes implementing a quality management system, and reaching and managing medical device manufacturer compliance with EU and Brazilian Health Regulatory Agency Anvisa’s requirements. Her prior versatile background includes multi-disciplinary leadership and business roles at innovative technology companies.

Jari Martelin
PhD, Clinical Study Manager
Uniogen
Finland

Jari Martelin has two decades of experience in clinical microbiology diagnostics and has been actively involved in developing and testing of various In Vitro Diagnostic (IVD) microbiology methods for diagnostic use. In the early years, he worked as a clinical microbiologist in clinical microbiology laboratories and was responsible particularly for the implementation and verification of molecular diagnostic methods and devices in routine use. Currently, he is working as a clinical study manager at Uniogen being responsible for the performance evaluation of newly developing assay products and their post-market surveillance studies.

Anu Mickels
CEO
Reagena
Finland

MBA, CEO of Oy Reagena Ltd since 2017. Before Reagena, she has worked within IVD and biotechnology industry in various management positions.

Emmi Rotgers
Specializing Physician
Fimlab Laboratoriot Oy, Finland

Emmi Rotgers became involved with studying analytical performance goals during her specialist training in Lcinical Chemistry HUSLAB, HUS Diagnostic Center. Later she relocated to Tampere and completed her training in Clinical Chemistry at Fimlab Laboratories. Prior to her career in Clinical Chemistry she pursued a career in basic research studying studying molecular mechanisms of gonadal development and function. She earned her PhD at the University of Turku and completed post-doctoral training the National Institute of Environmental Health Sciences (NIEHS) in USA. She is currently working as a clinical doctor in general practice to finish her specialist training.

Miia Salonen
Development Manager
GS1 Finland
Finland

Miia Salonen has worked at GS1 for over 10 years and is a specialist in the benefits of the GS1 system. Her role as Development Manager is to support UDI compliance and drive the use of global GS1 standards in the healthcare sector. Her special interest is in bringing the standards to life, i.e. finding valuable use cases and benefits for industry and healthcare providers.

Teemu Niskanen
Product Manager
Duodecim Publishing Company

Teemu Niskanen leads product development for population health management tools at Duodecim. He’s spent over a decade in London developing financial software for investment banking at Reuters. Transitioning from financial markets to healthcare technology has been a challenging but rewarding experience. Teemu is a technologist at heart, delighting users with great user experience.

Jari-Matti Sirkka
MSc, Director, Operations
Radiometer Turku
Finland

Director in Radiometer Turku Oy leading Operations. Extensive experience in R&D and Operations for Medical Devices, especially in the Diagnostic field.